May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The global pain management drugs market size was valued at USD 87.19 billion in 2025 and is expected to hit around USD 130.8 billion by 2035, growing at a CAGR of 4.14%.
July 2025
The global oxycodone drugs market size was valued at USD 6.68 billion in 2024 and is projected to reach around USD 11.53 billion by 2034 with a CAGR of 5.61%.
May 2026
The U.S. revenue cycle management market size was valued at USD 65.43 billion in 2025 and is predicted to hit around USD 191.67 billion by 2035, at a CAGR of 11.50%.
May 2026
The U.S. complex and chronic condition management market size is valued at USD 7.47 billion in 2026 and is expected to reach over USD 18.33 billion by 2035, with a registered CAGR of 11.18%.
March 2026
The U.S. absence management market size is projected to hit around USD 877.37 million by 2035, increasing from USD 355.52 million in 2025, with a CAGR of 9.59%.
March 2026
The global post-operative pain management market size is estimated to hit around USD 73.26 billion by 2035 increasing from USD 45.19 billion in 2025, with a CAGR of 4.95%.
February 2026
The U.S. generic drugs market size was exhibited at USD 146.04 billion in 2025 and is projected to hit around USD 243.70 billion by 2035 with a CAGR of 5.25%.
January 2026
The pain management therapeutics market size accounted for USD 88.19 billion in 2025 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
December 2025
The U.S. pharmacy benefit management market size is expected to hit around USD 1,041.11 billion by 2034 from USD 459.65 billion in 2025 with a CAGR of 9.7%.
November 2025
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 17.15 billion by 2034 increasing from USD 8.44 billion in 2025, with a CAGR of 8.18%.
November 2025
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
November 2025
The global pain management devices market size and is projected to hit around USD 13.06 billion by 2034 from USD 5.82 billion in 2025 with a CAGR of 9.40%.
August 2025
The U.S. category management software market size is estimated to hit around USD 1,535.24 million by 2034 increasing from USD 749.07 million in 2024, with a CAGR of 7.44%.
July 2025
The U.S. clinical trial management system market size was evaluated at USD 720 million in 2024 and is predicted to hit around USD 2,400 million by 2034, growing at a CAGR of 12.79%.
June 2025
The U.S. asthma drugs market size was evaluated at USD 8.79 billion in 2024 and is predicted to surge to around USD 14.36 billion by 2034 with a CAGR of 5.03%.
June 2025
Discover trends, key players, and growth drivers in the U.S. Investment Banking and Asset Management Market with in-depth market analysis.
August 2025
The global non-opioid pain patches market size was estimated at USD 991.63 million in 2024 and is projected to surpass around USD 1,816.48 million by 2034, with a CAGR of 6.24%.
July 2025
The U.S. healthcare facilities management market size was exhibited at USD 93 billion in 2024 and is predicted to be worth around USD 240.9 billion by 2034 with a CAGR of 9.99%.
August 2025
The global nefopam hydrochloride injection market size was estimated at USD 120.06 billion in 2024 and is expected to hit around USD 246.30 billion by 2034, growing at a CAGR of 7.45%.
May 2026
The facility management market size accounted for USD 1.53 trillion in 2025 and is expected to hit USD 2.49 trillion by 2035 at a CAGR of 4.98%.
May 2026
The global revenue cycle management market size surpassed USD 169.69 billion in 2025 and is projected to hit around USD 493.37 billion by 2035 with a CAGR of 11.26%.
May 2026
The global HIV drugs market size is estimated at USD 38.47 billion in 2025 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
May 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
May 2026
The global antifungal drugs market size was exhibited at USD 18.00 billion in 2025 and is projected to hit around USD 25.34 billion by 2035 with a CAGR of 3.49%.
May 2026
The U.S. endoscopes market size surpassed USD 5.19 billion in 2025 and is predicted to reach around USD 12.09 billion by 2035, at a notable CAGR of 8.82%.
May 2026
The global pharmacy inventory management software solutions and cabinet market size is estimated to hit around USD 15.23 billion by 2035 from USD 7.15 billion in 2025, at a CAGR of 7.85%.
May 2026
The pharmacy benefit management market size is expected to hit around USD 1,588.59 billion by 2035 from USD 670.19 billion in 2025 with a CAGR of 9.01%.
May 2026
The global NPL management market size was evaluated at USD 3.61 billion in 2025 and is predicted to hit around USD 6.59 billion by 2035, growing at a CAGR of 6.20%.
May 2026
The global product information management market size is expected to surpass around USD 121.48 billion by 2035 from USD 20.95 billion in 2025 with a solid CAGR of 19.22%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com